Alembic Pharma receives USFDA approval for Clonazepam
Alembic Pharmaceuticals has received USFDA approval for Clonazepam orally disintegrating tablets which are used for treatment of seizures, adjunct in the treatment of the Lennox-Gastaut […]
Approvals
Alembic Pharma receives USFDA approval for Bromfenac Ophthalmic Solution
Alembic Pharmaceuticals has received USFDA approval from for Bromfenac Ophthalmic Solution, used for treatment of post-operative inflammation and reduction of ocular pain in patients who […]
Alembic Pharma receives USFDA approval for Oseltamivir Phosphate
Alembic Pharmaceuticals has received final USFDA approval for Oseltamivir Phosphate capsules, used for treatment of influenza infection. The drug is therapeutically equivalent to the reference […]
Glenmark Pharma receives USFDA approval for Solifenacin Succinate
Glenmark has receive final USFDA approval for Solifenacin Succinate Tablets in strengths of 5 mg and 10 mg. The drug Solifenacin Succinate is a generic […]
Alembic Pharma receives USFDA approval for Solifenacin Succinate
Alembic Pharmaceuticals has received USFDA approval for Solifenacin Succinate tablets which are used for treatment of over-active bladder. The product Solifenacin Succinate is a generic […]
Alembic Pharmaceuticals receives USFDA approval for Carbidopa and Levodopa extended-release tablets
Alembic Pharmaceuticals has received USFDA approval for Carbidopa and Levodopa extended-release tablets which is used for treatment of Parkinson’s disease. The drug is therapeutically equivalent […]
Shilpa Medicare receives USFDA approvals for Docetaxel injection
Shilpa Medicare has received final USFDA approval for Docetaxel Injection, used for treatment of various types of cancers. The company will market the inaction in […]
Natco Pharma receives USFDA approval for Nitroglycerin Sublingual Tablet
Natco Pharma has received final ANDA nod from USFDA for chest pain tablets through its marketing partner Alvogen. The drug Nitroglycerin Sublingual Tablets in strengths […]
Cipla receives USFDA approval for Ambrisentan
Cipla has received the final USFDA approval for the Abbreviated New Drug Application (ANDA) for their Ambrisentan Tablets, 5 mg and 10 mg. The drug […]
Lupin Pharma receives USFDA approval for Fluoxetine
Lupin Pharma has received USFDA approval for its Fluoxetine Tablets USP, 10 mg and 20 mg to market the same in US markets. The drug […]